(Q72483293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

G A Lanfranchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

G Bazzocchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

C Brignola

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

F Sarti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

G Franzin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

A Battocchia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

G Labo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

P R Dal Monte

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 August 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

270-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

Sulphasalazine and salicylazosulphadimidine in ulcerative colitis

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

Biopsy studies in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

Medical management of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990523-7

7 January 2021

10.1016/S0140-6736(81)90523-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6114321%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference